June 4 2020 8:40pm

Flawed data influenced COVID-19 policies

The Lancet, the respected medical journal, is now retracting the key study that cast doubt on the safety of hydroxychloroquine. The anti-malaria drug is being researched as a potential treatment for COVID-19. Heather Yourex-West explains the dispute over some flawed data, and the pitfalls of rushing research.

Responsive site?

Video Home